US 12,303,711 B2
Enhanced treatment of brain disorders utilizing coordinated negative suppressive stimulation and related devices designed to achieve treatment
Fredric Schiffer, Newton Highland, MA (US)
Filed by Fredric Schiffer, Newton Highland, MA (US)
Filed on Nov. 15, 2024, as Appl. No. 18/948,675.
Application 18/948,675 is a division of application No. 17/393,074, filed on Aug. 3, 2021, granted, now 12,194,310.
Claims priority of provisional application 63/060,177, filed on Aug. 3, 2020.
Prior Publication US 2025/0073490 A1, Mar. 6, 2025
Int. Cl. A61N 5/00 (2006.01); A61M 21/02 (2006.01); A61N 5/06 (2006.01); A61M 21/00 (2006.01)
CPC A61N 5/0618 (2013.01) [A61M 21/02 (2013.01); A61M 2021/0027 (2013.01); A61M 2021/0066 (2013.01); A61M 2210/0662 (2013.01); A61N 2005/005 (2013.01); A61N 2005/0626 (2013.01); A61N 2005/0651 (2013.01); A61N 2005/0652 (2013.01)] 10 Claims
OG exemplary drawing
 
1. A method for enhanced treatment of a brain disorder characterized by neurologic or psychiatric disorder symptomology with a lateralized difference in hemispheric emotional valence, utilizing coordinated negative suppressive stimulation, comprising
identifying a patient with a brain disorder;
measuring a left hemispheric emotional valence for a left hemisphere of a brain of the patient and a right hemispheric emotional valence for a right hemisphere of the brain of the patient to identify a patient with a lateralized difference in hemispheric emotional valence;
determining which hemisphere of the brain of the patient with a lateralized difference in hemispheric emotional valence has a more positive valence, and which hemisphere of the brain has a more negative valence;
transcranially applying light energy having a wavelength of between 300 nm to 1500 nm and a power density at the scalp of up to 10 W/cm2 to the brain of said patient with the brain disorder with lateralized difference in hemispheric emotional valence, wherein the light energy is asymmetrically transcranially applied to the lateral forehead to activate the underlying cortex of the brain hemisphere with a more positive valence for a defined period; and
coordinated application of negative suppressive stimulation of the brain hemisphere with the more negative valence, wherein the negative suppressive stimulation is coordinated with the asymmetric transcranial application to the forehead of the patient to activate the underlying cortex of the brain hemisphere with the more positive valence,
such that the brain disorder with lateralized difference in hemispheric emotional valence is treated in said patient.